D00503 | |
D number | D00503 |
Classification | Drug |
Name | Perphenazine (JP17/USP/INN); Trilafon (TN) |
Component | - |
Formula | C21H26ClN3OS |
Exact mass | 403.1485 |
Mol weight | 403.9686 |
Structural formula | ![]() |
Sequence | - |
Sequence type | - |
Source | - |
Upper DGroup | Neuropsychiatric agent DG01905 Phenothiazine antipsychotics DG01478 Dopamine antagonist DG01474 Dopamine D2-receptor antagonist Cyp substrate DG01644 CYP2D6 substrate Cyp inhibitor DG01645 CYP2D6 inhibitor |
Remark | Same as: C07427 Therapeutic category: 1172 ATC code: N05AB03 Chemical group: DG00875 |
Activity | - |
Disease | - |
Comment | Phenothiazine derivative |
Target | DRD2 [HSA:1813] [KO:K04145] |
Metabolism | Enzyme: CYP2D6 [HSA:1565] |
Interaction | Genomic biomarker: CYP2D6 [HSA:1565] |
Other DBs | CAS: 58-39-9 PubChem: 7847569 ChEBI: 8028 ChEMBL: CHEMBL567 DrugBank: DB00850 LigandBox: D00503 NIKKAJI: J1.387K |
KCF data | - |